Sign In
Buy ACA
$123.80
+0.95 (+0.773%)
At Close: Jun 03, 2026
ACA’s Medicaid Expansion Reduced Catastrophic Health Expenses
04:16pm, Friday, 28'th Feb 2020
Financial “protection” from catastrophic healthcare expenses improved dramatically thanks to the Medicaid expansion under the Affordable Care Act, a new analysis shows.
US$52.20 - That's What Analysts Think Arcosa, Inc. Is Worth After These Results
02:27pm, Friday, 28'th Feb 2020
Arcosa, Inc. (NYSE:ACA) shares fell 4.1% to US$42.55 in the week since its latest yearly results. It was a credible...
US$52.20 – That’s What Analysts Think Arcosa, Inc. Is Worth After These Results
02:24pm, Friday, 28'th Feb 2020
Last week, you might have seen that Arcosa, Inc. (NYSE:ACA) released its annual result to the market. The early...
Arcosa Inc (NYSE:ACA) Short Interest Down 25.4% in February
11:42am, Friday, 28'th Feb 2020
Arcosa Inc (NYSE:ACA) saw a significant decline in short interest in the month of February. As of February 14th, there was short interest totalling 574,900 shares, a decline of 25.4% from the January
Arcosa (NYSE:ACA) Trading 7.9% Higher After Better-Than-Expected Earnings
07:38am, Friday, 28'th Feb 2020
Arcosa Inc (NYSE:ACA)’s share price traded up 7.9% on Thursday after the company announced better than expected quarterly earnings. The company traded as high as $44.23 and last traded at $42.55, 64
Arcosa, Inc (ACA) Q4 2019 Earnings Call Transcript
10:00pm, Thursday, 27'th Feb 2020
ACA earnings call for the period ending December 31, 2019.
Arcosa, Inc.'s (ACA) CEO Antonio Carrillo on Q4 2019 Results - Earnings Call Transcript
07:49pm, Thursday, 27'th Feb 2020
Arcosa, Inc. (NYSE:ACA) Q4 2019 Results Earnings Conference Call February 27, 2020, 8:30 AM ET Company Participants Gail Peck - Senior Vice President, Finance a
Are Investors Undervaluing Arcosa (ACA) Right Now?
04:50pm, Thursday, 27'th Feb 2020
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Are Investors Undervaluing Arcosa (ACA) Right Now?
04:50pm, Thursday, 27'th Feb 2020
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
How Best to Fix the US Healthcare System? For Physicians, It Starts with Affordability and Access, Says InCrowd Data
04:00pm, Thursday, 27'th Feb 2020
As healthcare reform dominates political discourse, those who know the US healthcare market perhaps best—US physicians—reported significantly higher concerns for healthcare affordability and acces
Aegion's (AEGN) Q4 Earnings and Revenues Miss Estimates
02:42pm, Thursday, 27'th Feb 2020
Aegion's (AEGN) Q4 results primarily reflect lower contribution from Corrosion Protection.
CREDIT AGRICOLE : Société Générale reste à l'Achat | Zone bourse
10:46am, Thursday, 27'th Feb 2020
Société Générale a confirmé sa recommandation dAchat et son objectif de cours de 15 euros sur Crédit Agricole. Le bureau détudes signale que la banque pourrait démanteler entièrement le m
Arcosa Inc to Post FY2019 Earnings of $2.30 Per Share, Oppenheimer Forecasts (NYSE:ACA)
06:10am, Thursday, 27'th Feb 2020
Arcosa Inc (NYSE:ACA) – Stock analysts at Oppenheimer boosted their FY2019 earnings estimates for shares of Arcosa in a report issued on Monday, February 24th. Oppenheimer analyst I. Zaffino now ant
Arcosa, Inc. Announces Fourth Quarter and Full Year 2019 Results and Provides 2020 Guidance
09:15pm, Wednesday, 26'th Feb 2020
Arcosa, Inc. (NYSE: ACA) ("Arcosa" or the "Company"), a provider of infrastructure-related products and solutions, today announced results for the fourth quarter and full year ended December 31, 2019.
Arcosa (ACA) Upgraded to Strong Buy: Here's Why
05:00pm, Wednesday, 26'th Feb 2020
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
